Nothing exciting. It is nice to see a little more detail on the general met testing strategy and scope split between ANSTO, Simulus and IMO. It's taking a while, but if it means we're going to get comprehensive results across a range of variables then I'm happy to wait.
- Forums
- ASX - By Stock
- MRD
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MRD (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.784M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $588 | 588.3K |
Featured News
MRD (ASX) Chart |